Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Nathanson

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Journal of Biomedical Materials Research|June 1, 1996
Effects of titanium on transcriptional and post-transcriptional regulation of fibronectin in human fibroblastsL Chou, J D Firth, D Nathanson, et al.
Diabetologia|November 26, 2009
Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart diseaseD Nathanson, B Zethelius, C Berne, et al.
Journal of Neuroscience Research|November 15, 1996
Re-entry into the cell cycle is required for bFGF-induced oligodendroglial dedifferentiation and survivalJ B Grinspan, M F Reeves, M J Coulaloglou, et al.
Annals of Surgical Oncology|March 1, 1997
Sentinel lymph node metastasis in experimental melanoma: relationships among primary tumor size, lymphatic vessel diameter and 99mTc-labeled human serum albumin clearanceS D Nathanson, P Anaya, M Avery, et al.
Annals of Surgical Oncology|January 5, 2002
Pathways of lymphatic drainage from the breastS D Nathanson, D L Wachna, D Gilman, et al.
Diabetologia|January 17, 2012
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safetyD Nathanson, B Ullman, U Löfström, et al.
Surgical Forum|January 1, 1979
Serologically defined B-lymphocyte antigen expression in patients with malignant melanomaS D Nathanson, M S Park, I Drew, et al.
Diabetes, Obesity & Metabolism|February 6, 2016
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptorV Darsalia, M Larsson, G Lietzau, et al.
Transplantation Proceedings|March 1, 1980
First and second B-lymphocyte antigen expression in malignant melanomaS D Nathanson, M S Park, S I Drew, et al.
Surgical Oncology|August 28, 2016
The predictive value of increased sentinel lymph node volume in breast cancerB A Krasnick, S D Nathanson, C N Arbabi, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Journal of Biomedical Materials Research|June 1, 1996
Effects of titanium on transcriptional and post-transcriptional regulation of fibronectin in human fibroblastsL Chou, J D Firth, D Nathanson, et al.
Diabetologia|November 26, 2009
Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart diseaseD Nathanson, B Zethelius, C Berne, et al.
Journal of Neuroscience Research|November 15, 1996
Re-entry into the cell cycle is required for bFGF-induced oligodendroglial dedifferentiation and survivalJ B Grinspan, M F Reeves, M J Coulaloglou, et al.
Annals of Surgical Oncology|March 1, 1997
Sentinel lymph node metastasis in experimental melanoma: relationships among primary tumor size, lymphatic vessel diameter and 99mTc-labeled human serum albumin clearanceS D Nathanson, P Anaya, M Avery, et al.
Annals of Surgical Oncology|January 5, 2002
Pathways of lymphatic drainage from the breastS D Nathanson, D L Wachna, D Gilman, et al.
Diabetologia|January 17, 2012
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safetyD Nathanson, B Ullman, U Löfström, et al.
Surgical Forum|January 1, 1979
Serologically defined B-lymphocyte antigen expression in patients with malignant melanomaS D Nathanson, M S Park, I Drew, et al.
Diabetes, Obesity & Metabolism|February 6, 2016
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptorV Darsalia, M Larsson, G Lietzau, et al.
Transplantation Proceedings|March 1, 1980
First and second B-lymphocyte antigen expression in malignant melanomaS D Nathanson, M S Park, S I Drew, et al.
Surgical Oncology|August 28, 2016
The predictive value of increased sentinel lymph node volume in breast cancerB A Krasnick, S D Nathanson, C N Arbabi, et al.
Pageof 14